Sugalski A, Grimes A, Nuno M, Ramakrishnan S, Beauchemin M, Robinson P
Pediatr Blood Cancer. 2024; 71(11):e31295.
PMID: 39238137
PMC: 11464177.
DOI: 10.1002/pbc.31295.
Paw Cho Sing E, Tomlinson G, Schechter T, Ali M, Phelan R, Rassekh S
Support Care Cancer. 2024; 32(8):552.
PMID: 39052128
DOI: 10.1007/s00520-024-08732-8.
Ames M, Patel P, Dupuis L, Koo A
J Oncol Pharm Pract. 2024; 31(2):251-255.
PMID: 38425048
PMC: 11898370.
DOI: 10.1177/10781552241233489.
Eghbali A, Bagherloo T, Ghasemi A, Afzal R, Eghbali A, Ghaffari K
Adv Biomed Res. 2023; 12:158.
PMID: 37564446
PMC: 10410408.
DOI: 10.4103/abr.abr_356_22.
Parsons S, Beauchemin M, Dupuis L, Sugalski A, Wolfson J, Santacroce S
Pediatr Blood Cancer. 2023; 70 Suppl 6:e30579.
PMID: 37469004
PMC: 10686255.
DOI: 10.1002/pbc.30579.
Chemo assist for children mobile health application to manage chemotherapy-related symptoms in acute leukemia in Indonesia: a user-centered design approach.
Novrianda D, Herini E, Haryanti F, Supriyadi E, Lazuardi L
BMC Pediatr. 2023; 23(1):274.
PMID: 37254039
PMC: 10227782.
DOI: 10.1186/s12887-023-04076-0.
The emerging role of olanzapine in paediatric CINV control: A review.
Barusic A
Medicine (Baltimore). 2022; 101(50):e32116.
PMID: 36550859
PMC: 9771166.
DOI: 10.1097/MD.0000000000032116.
Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis.
Patel P, Robinson P, Wahib N, Cheung P, Wong T, Cabral S
Support Care Cancer. 2022; 30(11):8855-8869.
PMID: 35953731
PMC: 10153509.
DOI: 10.1007/s00520-022-07287-w.
Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children.
Lee S, Kim S, Oh M, Lee J
Children (Basel). 2020; 7(9).
PMID: 32948015
PMC: 7552625.
DOI: 10.3390/children7090140.
Creation of a chemotherapy-induced nausea/vomiting dashboard to improve outcomes for pediatric cancer patients.
Walsh A, Hess J, Rees M, Wetmore C, Vadiya V
Support Care Cancer. 2020; 29(3):1549-1555.
PMID: 32734390
DOI: 10.1007/s00520-020-05652-1.
Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Cabanillas Stanchi K, Vek J, Schlegel P, Rupprecht J, Flaadt T, Weber S
J Cancer Res Clin Oncol. 2020; 146(4):1089-1100.
PMID: 32056007
PMC: 7085480.
DOI: 10.1007/s00432-020-03143-8.
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow....
Nava T, Ansari M, Dalle J, de Heredia C, Gungor T, Trigoso E
Bone Marrow Transplant. 2020; 55(6):1126-1136.
PMID: 32029909
DOI: 10.1038/s41409-020-0818-4.
Guideline concordant care for prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults.
Beauchemin M, Sung L, Hershman D, Weng C, Dupuis L, Schnall R
Support Care Cancer. 2020; 28(10):4761-4769.
PMID: 31974769
PMC: 7375924.
DOI: 10.1007/s00520-020-05310-6.
Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies.
Cabanillas Stanchi K, Ebinger M, Hartmann U, Queudeville M, Feucht J, Ost M
Drug Des Devel Ther. 2019; 13:3439-3451.
PMID: 31686784
PMC: 6777642.
DOI: 10.2147/DDDT.S214264.
Systematic review of the effectiveness of complementary and alternative medicine on nausea and vomiting in children with cancer: a study protocol.
Ho K, Lam K, Chung J, Xia W, Cheung A, Ho L
BMJ Open. 2019; 9(10):e031834.
PMID: 31628132
PMC: 6803108.
DOI: 10.1136/bmjopen-2019-031834.
Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial.
Lown E, Banerjee A, Vittinghoff E, Dvorak C, Hartogensis W, Melton A
Glob Adv Health Med. 2019; 8:2164956119870444.
PMID: 31453017
PMC: 6696841.
DOI: 10.1177/2164956119870444.
Latest Update on Prevention of Acute Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients.
Sherani F, Boston C, Mba N
Curr Oncol Rep. 2019; 21(10):89.
PMID: 31418119
PMC: 6695477.
DOI: 10.1007/s11912-019-0840-0.
Optimizing symptom control in children and adolescents with cancer.
Dupuis L, Cook S, Robinson P, Tomlinson D, Vettese E, Sung L
Pediatr Res. 2019; 86(5):573-578.
PMID: 31357207
DOI: 10.1038/s41390-019-0516-3.
Chemotherapy-induced nausea and vomiting control in pediatric patients receiving ifosfamide plus etoposide: a prospective, observational study.
Patel P, Lavoratore S, Flank J, Kemp M, Vennettilli A, Vol H
Support Care Cancer. 2019; 28(2):933-938.
PMID: 31177392
DOI: 10.1007/s00520-019-04903-0.
Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma.
Giagnuolo G, Buffardi S, Rossi F, Petruzziello F, Tortora C, Buffardi I
PLoS One. 2019; 14(4):e0215295.
PMID: 30978265
PMC: 6461284.
DOI: 10.1371/journal.pone.0215295.
